Tiziana Life Sciences Ltd (NASDAQ:TLSA) has completed enrollment in its Phase 2 clinical trial evaluating foralumab for ...
Veeva Systems Inc. (NYSE:VEEV) is one of the best stocks to buy with wide moats. The latest moat-relevant update came on May ...
Digital analytics is slowly and steadily transforming the life sciences industry due to its ability to process large volumes of complex data and produce in-depth insights, thereby improving the ...
Data reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of ...
Strong Buy on WVE-N531 and WVE-006 catalysts, Phase data, and cash runway into 2028. Click for this WVE stock update.
The Uniformed Services University of the Health Sciences intends to procure, on personal service basis, the operation of the Spaceline space life sciences bibliographic services unit, composed of ...
Nausea - a common barrier to treatment adherence with smoking cessation therapies - was reported in only 2.5% of participants over 52 weeks of continuous exposure¹ SEATTLE and VANCOUVER, British ...
The U.S. life sciences industry entered 2026 with surprising momentum, following threats of tariffs and disrupted trade, NIH funding cuts, and a sluggish IPO market. Accounting for more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results